000153725 001__ 153725
000153725 005__ 20240229123048.0
000153725 0247_ $$2doi$$a10.3390/nu12020452
000153725 0247_ $$2pmid$$apmid:32053988
000153725 0247_ $$2altmetric$$aaltmetric:76125314
000153725 037__ $$aDKFZ-2020-00422
000153725 041__ $$aeng
000153725 082__ $$a610
000153725 1001_ $$0P:(DE-He78)b4004ee4b650b575447f59a4a0471312$$aSowah, Solomon$$b0$$eFirst author$$udkfz
000153725 245__ $$aChanges in Plasma Short-Chain Fatty Acid Levels after Dietary Weight Loss Among Overweight and Obese Adults over 50 Weeks.
000153725 260__ $$aBasel$$bMDPI$$c2020
000153725 3367_ $$2DRIVER$$aarticle
000153725 3367_ $$2DataCite$$aOutput Types/Journal article
000153725 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601039656_17569
000153725 3367_ $$2BibTeX$$aARTICLE
000153725 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153725 3367_ $$00$$2EndNote$$aJournal Article
000153725 500__ $$a#EA:C020#
000153725 520__ $$aGut microbial-derived short-chain fatty acids (SCFAs) may regulate energy homeostasis and exert anti-carcinogenic, immunomodulatory and anti-inflammatory effects. Smaller trials indicate that dietary weight loss may lead to decreased SCFA production, but findings have been inconclusive. SCFA concentrations were measured by HPLC-MS/MS in plasma samples of 150 overweight or obese adults in a trial initially designed to evaluate the metabolic effects of intermittent (ICR) versus continuous (CCR) calorie restriction (NCT02449148). For the present post hoc analyses, participants were classified by quartiles of weight loss, irrespective of the dietary intervention. Linear mixed models were used to analyze weight-loss-induced changes in SCFA concentrations after 12, 24 and 50 weeks. There were no differential changes in SCFA levels across the initial study arms (ICR versus CCR versus control) after 12 weeks, but acetate concentrations significantly decreased with overall weight loss (mean log-relative change of -0.7 ± 1.8 in the lowest quartile versus. -7.6 ± 2 in the highest, p = 0.026). Concentrations of propionate, butyrate and other SCFAs did not change throughout the study. Our results show that weight-loss, achieved through calorie restriction, may lead to smaller initial decreases in plasma acetate, while plasma SCFAs generally remain remarkably stable over time.
000153725 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153725 588__ $$aDataset connected to CrossRef, PubMed,
000153725 7001_ $$aHirche, Frank$$b1
000153725 7001_ $$aMilanese, Alessio$$b2
000153725 7001_ $$0P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aJohnson, Theron S$$b3$$udkfz
000153725 7001_ $$0P:(DE-He78)9a183bfc8348c1db81a0ecf1458d0708$$aGrafetstätter, Mirja$$b4$$udkfz
000153725 7001_ $$0P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aSchübel, Ruth$$b5
000153725 7001_ $$aKirsten, Romy$$b6
000153725 7001_ $$aUlrich, Cornelia M$$b7
000153725 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b8$$udkfz
000153725 7001_ $$aZeller, Georg$$b9
000153725 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b10$$udkfz
000153725 7001_ $$aStangl, Gabriele I$$b11
000153725 773__ $$0PERI:(DE-600)2518386-2$$a10.3390/nu12020452$$gVol. 12, no. 2, p. 452 -$$n2$$p452$$tNutrients$$v12$$x2072-6643$$y2020
000153725 909CO $$ooai:inrepo02.dkfz.de:153725$$pVDB
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b4004ee4b650b575447f59a4a0471312$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9a183bfc8348c1db81a0ecf1458d0708$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000153725 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000153725 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153725 9141_ $$y2020
000153725 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNUTRIENTS : 2017
000153725 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153725 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153725 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153725 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000153725 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000153725 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000153725 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000153725 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000153725 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153725 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153725 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153725 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000153725 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153725 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000153725 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000153725 980__ $$ajournal
000153725 980__ $$aVDB
000153725 980__ $$aI:(DE-He78)C020-20160331
000153725 980__ $$aUNRESTRICTED